Company Filing History:
Years Active: 2017
Title: Innovator Spotlight: Ashwini Gadre and Her Breakthrough in Pharmaceutical Formulation
Introduction: Ashwini Gadre, an accomplished inventor based in Brisbane, California, has made significant contributions to the field of pharmaceuticals. With her innovative spirit, she has developed a novel pharmaceutical composition that enhances the delivery of active ingredients. Her work exemplifies the intersection of science and creativity in the quest for improved medical solutions.
Latest Patents: One of Ashwini's notable achievements is her patent titled "Matrix-based pulse release pharmaceutical formulation." This invention relates to an oral pulse release pharmaceutical composition that includes a polymer matrix core. It efficiently distributes at least one pharmaceutically active ingredient within the core and on its outer surface. Among the various active ingredients, amphetamine salts are specifically mentioned, showcasing the versatility of her formulation. Additionally, her patent outlines a method for preparing an immediate release component within a solid pharmaceutical formulation, further advancing the field of drug delivery systems.
Career Highlights: Ashwini is associated with Mallinckrodt, Inc., a prominent company dedicated to specialty pharmaceuticals. Her expertise contributes to the research and development efforts aimed at creating innovative therapeutic solutions that address complex health issues. Her work signifies a commitment to improving patient outcomes through cutting-edge formulations.
Collaborations: Throughout her career, Ashwini has collaborated with esteemed colleagues such as Mark R Benmuvhar and Brian Kai-Ming Cheng. These partnerships reflect her dedication to teamwork and the sharing of knowledge within the scientific community, enhancing the quality of her inventions.
Conclusion: Ashwini Gadre represents the innovation-driven spirit of modern inventors. Her contributions in the form of a groundbreaking patent not only highlight her ingenuity but also underscore the importance of collaboration in scientific advancement. As she continues her work at Mallinckrodt, Inc., her inventions promise to lead to new possibilities in the pharmaceutical industry, paving the way for improved health solutions.